Hunan Jingfeng Pharmaceutical Co (000908.SZ) Stock Price
Hunan Jingfeng Pharmaceutical Co Price
Over the last 19 years Hunan Jingfeng Pharmaceutical Co grew revenue by 2.5% annually, reaching 378.11 M CNY. Earnings per share have grown at 20.1% per year over the last 18 years. For Hunan Jingfeng Pharmaceutical Co, the net margin of -21.4% is down versus -20.2% a few years ago. At today's price the dividend yield works out to roughly 0.17%. The payout ratio is around 5% of earnings.
Hunan Jingfeng Pharmaceutical Co stock price
Hunan Jingfeng Pharmaceutical Co business model & stock analysis
Frequently asked questions about Hunan Jingfeng Pharmaceutical Co
6 analysts currently rate the Hunan Jingfeng Pharmaceutical Co stock: 0 recommend buying, 3 holding and 3 selling.
Converted at the current exchange rate, the Hunan Jingfeng Pharmaceutical Co share trades at 0.80 EUR (6.02 CNY).
The Hunan Jingfeng Pharmaceutical Co share (000908.SZ) is listed on 1 stock exchanges, including: Shenzhen (000908.SZ).
The revenue cannot currently be calculated for Hunan Jingfeng Pharmaceutical Co.
The profit cannot currently be calculated for Hunan Jingfeng Pharmaceutical Co.
The P/E ratio cannot be calculated for Hunan Jingfeng Pharmaceutical Co at the moment.
The P/S cannot be calculated for Hunan Jingfeng Pharmaceutical Co currently.
The Eulerpool Quality Score for Hunan Jingfeng Pharmaceutical Co is 1/10.
The ISIN of Hunan Jingfeng Pharmaceutical Co is CNE000000Y11. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Hunan Jingfeng Pharmaceutical Co is 000908.SZ. The ticker symbol is used to trade Hunan Jingfeng Pharmaceutical Co shares on the stock exchange.
Hunan Jingfeng Pharmaceutical Co stock
Hunan Jingfeng Pharmaceutical Co Peer Group
Hunan Jingfeng Pharmaceutical Co Ticker
Hunan Jingfeng Pharmaceutical Co FIGI
All fundamentals and in-depth analysis of Hunan Jingfeng Pharmaceutical Co
Our stock analysis for Hunan Jingfeng Pharmaceutical Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hunan Jingfeng Pharmaceutical Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.